Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a Eu... von Castellano, D., del Muro, X. Garcia, Pérez-Gracia, J. L., González-Larriba, J. L., Abrio, M. V., Ruiz, M. A., Pardo, A., Guzmán, C., Cerezo, S. Díaz, Grande, E.

Volltext

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-I- as first-line systemic therapy for patients with metastatic renal cell carcinoma in a E... von Castellano, D, del Muro, XGarcia, Perez-Gracia, J L, GonzA!lez-Larriba, JL, Abrio, M V, Ruiz, MA, Pardo, A, GuzmA!n, C, Cerezo, SDiaz, Grande, E

Volltext

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma i... von Castellano, D, del Muro, X Garcia, Pérez-Gracia, J L, González-Larriba, J L, Abrio, M V, Ruiz, M A, Pardo, A, Guzmán, C, Cerezo, S Díaz, Grande, E

Volltext

Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy von Martínez-Fernández, E, Gil-Néciga, E, López-Domínguez, J M, Casado-Chocán, J L, Garzón, F, Franco, E, Abrio, M V

Volltext

Rituximab maintenance after R-CHOP in the first-line treatment of follicular lymphoma: A GOTEL phase II trial von Rueda, A., Provencio, M., Abrio, M., Gómez-Codina, J., Llanos, M., Delgado, J., Rifá, J., Sabin, P., Vélez de Mendizabal, E., Baz, V.

Volltext